Outcome of percutaneous hybrid coronary revascularization: Bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world

Canadian Journal of Cardiology

Volumn 21, Issue 14, 2005, Pages 1281-1285

  Fineschi, Massimo ^a   Gori, Tommaso ^a   Pierli, Carlo ^a   Casini, Stefano ^a   Sinicropi, Giuseppe ^a   Buti, Alberto ^a   Del Pasqua, Alessia ^a   Bravi, Achille ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Bare metal stent; Percutaneous coronary intervention; Sirolimus

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; METAL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG DOSE REGIMEN; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; REOPERATION; RISK ASSESSMENT; THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; HEART CATHETERIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 31744439340     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rajagopal V, Rockson SG. Coronary restenosis: A review of mechanisms and management. Am J Med 2003;115:547-53.
2. Morice MC, Serruys PW, Sousa JE, et al; RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
3. Schofer J, Schluter M, Gershlick AH, et al; E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
4. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: The first clinical experience. J Am Coll Cardiol 2003;41:184-9.
5. Degertekin M, Arampatzis CA, Lemos PA, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 2004;93:826-9.
6. Lemos PA, Hoye A, Goedhart D, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004;109:1366-70.
7. Orlic D, Bonizzoni E, Stankovic G, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: Immediate and mid-term results. J Am Coll Cardiol 2004;43:1154-60.
8. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004;109:701-5.
9. Schampaert E, Cohen EA, Schluter M, et al; C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-5.
10. US Food and Drug Administration. Cordis Corporation issues a health care professional letter regarding the CYPHER stent. FDA News 3 AD. (Version current at November 14, 2005).
11. Moussa I, Reimers B, Moses J, et al. Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting. Circulation 1997;96:3873-9.
12. Galanaud JP, Delavennat J, Durand-Zaleski I. A break-even price calculation for the use of sirolimus-eluting stents in angioplasty. Clin Ther 2003;25:1007-16.
13. O'Neill WW, Leon MB. Drug-eluting stents: Costs versus clinical benefit. Circulation 2003;107:3008-11.
14. Greenberg D, Bakhai A, Cohen DJ. Can we afford to eliminate restenosis? Can we afford not to? J Am Coll Cardiol 2004;43:513-8.